Home Compare AMGN vs SNPS
Stock Comparison · Structural lead, mixed market

Amgen vs Synopsys: Which Stock Looks Stronger in 2026?

Amgen holds the cleaner structural position, with valuation as the main driver and growth adding further support. Synopsys does not offset that deficit through any equally strong structural edge elsewhere. The market setup broadly confirms the structural lead — Amgen holds the more constructive position. That puts structure and market broadly in agreement — Amgen's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in valuation, but growth adds another real layer to the result. Amgen Inc. leads by 23 points on the overall comparison score.

Trajectory Similarity
0.60
Moderately similar
Peer-set rank: #12
within Amgen Inc.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

Most of the shared profile comes through margin trend and investment intensity.

Similarity drivers
margin trendinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AMGN
Amgen Inc.
63
Peer-Score
Signal qualityHigh
vs
SNPS
Synopsys, Inc.
40
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: AMGN vs SNPS Profitability 50 33 Stability 57 50 Valuation 73 35 Growth 75 51 AMGN SNPS
Gap Ranking
#1 Valuation +38
#2 Growth +24
#3 Profitability +17
#4 Stability +7
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AMGN and SNPS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AMGNSNPS Relative valuation Structural strength

Amgen Inc. looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
On valuation, Amgen Inc. ranks near the top of the group; Synopsys, Inc. sits in the weaker half.
Growth
On growth, the edge still sits with Amgen Inc., even though both profiles look solid.
Valuation — Dominant Gap
AMGN
73
SNPS
35
Gap+38in favour of AMGN

The multiple-based pricing edge comes from a forward P/E that is 8.2 turns lower.

What keeps the gap from being one-sided

Synopsys, Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

Valuation is the clearest driver, and growth also supports Amgen Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the AMGN vs SNPS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-growth comparisons

Explore how AMGN and SNPS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.